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of mild streptozotocin-induced diabetes 
on lesion severity and markers of inflammation 
evaluated in obese, obese and diabetic, 
and lean control animals
Trine Pagh Ludvigsen1,2, Rikke Kaae Kirk3, Berit Østergaard Christoffersen2, Henrik Duelund Pedersen2, 
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Abstract 
Background: From a pharmacological perspective, readily-available, well-characterized animal models of cardiovas-
cular disease, including relevant in vivo markers of atherosclerosis are important for evaluation of novel drug candi-
dates. Furthermore, considering the impact of diabetes mellitus on atherosclerosis in human patients, inclusion of this 
disease aspect in the characterization of a such model, is highly relevant. The objective of this study was to evaluate 
the effect of mild streptozotocin-induced diabetes on ex- and in vivo end-points in a diet-induced atherosclerotic 
minipig model.
Methods: Castrated male Göttingen minipigs were fed standard chow (CD), atherogenic diet alone (HFD) or with 
superimposed mild streptozotocin-induced diabetes (HFD-D). Circulating markers of inflammation (C-reactive protein 
(CRP), oxidized low-density lipoprotein (oxLDL), plasminogen activator inhibitor-1, lipid and glucose metabolism 
were evaluated together with coronary and aortic atherosclerosis after 22 or 43 diet-weeks. Group differences were 
evaluated by analysis of variance for parametric data and Kruskal–Wallis test for non-parametric data. For qualitative 
assessments, Fisher’s exact test was applied. For all analyses, p < 0.05 was considered statistically significant.
Results: Overall, HFD and HFD-D displayed increased CRP, oxLDL and lipid parameters compared to CD at both time 
points. HFD-D displayed impaired glucose metabolism as compared to HFD and CD. Advanced atherosclerotic lesions 
were observed in both coronary arteries and aorta of HFD and HFD-D, with more advanced plaque findings in the 
aorta but without differences in lesion severity or distribution between HFD and HFD-D. Statistically, triglyceride was 
positively (p = 0.0039), and high-density lipoprotein negatively (p = 0.0461) associated with aortic plaque area.
Conclusions: In this model, advanced coronary and aortic atherosclerosis was observed, with increased levels of 
inflammatory markers, clinically relevant to atherosclerosis. No effect of mild streptozotocin-induced diabetes was 
observed on plaque area, lesion severity or inflammatory markers.
© 2015 Ludvigsen et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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fractions, plasma markers of inflammation are becoming 
increasingly used for improved prediction of cardiovas-
cular disease outcome [18, 19]. Relevant inflammatory 
markers, e.g. C-reactive protein (CRP) and oxidized low-
density lipoprotein (oxLDL), are suspected to be involved 
in endothelial cell inflammation as well as being mecha-
nistically involved in formation of the atheroma [20, 21]. 
Other markers, such as tissue plasminogen activator and 
plasminogen activator inhibitor-1 (PAI-1) relate to hemo-
stasis and impaired fibrinolysis, and especially PAI-1 has 
been recognized as an indicator in relation to thrombo-
genicity of atherosclerotic plaques [19, 22]. These may be 
relevant biomarkers of atherosclerosis in pigs as well as in 
humans, but need further investigation.
The aim of this study was to evaluate the effect of mild 
diabetes on aortic and coronary plaque burden and lesion 
advancement in diet-induced atherosclerotic and mildly 
diabetic Göttingen minipigs. In addition, the association 
between plaque burden and circulating metabolic and 
inflammatory markers, relevant to atherosclerosis was 
evaluated in animals euthanized after 22 or 43 weeks of 
atherogenic diet-feeding.
Methods
Animals, diet and housing
Castrated male Göttingen minipigs (Ellegaard A/S, Dal-
mose, DK), were housed at research facilities of Uni-
versity of Copenhagen. Using a staggered design, two 
cohorts (A and B) with an equal animal distribution in 
each cohort, mean age 11 weeks at study start, were ran-
domized to three groups; lean control (CD, n = 12) fed 
a standard minipig diet (Mini-pig, Testdiet, Essex, UK) 
according to breeders recommendations, and a high-fat/
high-cholesterol group (HFD, n =  12) as well as a low-
grade diabetic group (HFD-D, n = 12), both fed an ather-
ogenic diet with 2 % cholesterol and 0.7 % sodium cholate 
(Ossabaw atherosclerotic diet type 5B4L, TestDiet®, 
St. Louis, MO, USA). All animals were fed a total daily 
amount of 2–2.5  % of bodyweight (evaluated weekly) 
divided into two daily meals. Animals had free access 
to water and bedding material and were group-housed, 
except for periods with intravenous (IV) catheters 
implanted. Animals from each cohort were euthanized at 
two different time points: After 22 weeks of diet feeding 
at a mean age of 33 weeks (CD, n = 6 and HFD, n = 6) or 
43 weeks of diet-feeding at a mean age of 55 weeks (CD, 
n = 6, HFD, n = 6 and HFD-D, n = 12). The study was 
approved by the Animal Experiments Inspectorate, Min-
istry of Justice, DK.
Background
Cardiovascular complications related to diabetes mel-
litus are well-known and with a global obesity epi-
demic, metabolic syndrome including pre-diabetic 
conditions such as insulin resistance and hypergly-
cemia has become a major challenge to global health 
[1]. Despite uncertainty regarding pathophysiological 
mechanisms, diabetes mellitus is known to be associ-
ated with increased cardiovascular risk in humans [2] 
and proposed to accelerate atherosclerosis in porcine 
models [3, 4]. Highly comparable cardiovascular anat-
omy and physiology, combined with a diet-induced 
plasma cholesterol profile preponderant in pro-athero-
genic lipoproteins, render porcine models attractive in 
research of atherosclerosis [5, 6]. Atherosclerosis devel-
ops in similar predilection sites as in humans and sev-
eral studies indicate development of advanced lesions, 
highly comparable to human atherosclerosis [3, 7–9]. 
Recent data from genetically-modified pigs also show 
advanced lesions [10, 11], however limited availabil-
ity and substantial cost of these models often restrict 
their use. Another important consideration in relation 
to porcine models is size, which often is a challenge in 
early drug development. The Göttingen minipig is one 
of the smaller minipig breeds and in addition, studies 
indicate a greater susceptibility of the breed to develop 
atherosclerosis as compared to domestic breeds [12]. 
The breed is well described in relation to glucose 
metabolism and obesity, with propensity to develop 
various aspects of the metabolic syndrome including 
insulin resistance and dyslipidemia [13–15]. Overt dia-
betes does generally not develop in pigs and induction, 
e.g. chemically, is therefore necessary [16]. Usually, in 
studies of diabetic atherosclerotic pigs, long-term sus-
tained hyperglycemia is applied to accelerate the ath-
erosclerosis [4], potentially leading to adverse effects 
including wasting or deleterious non-thriving of the 
animals, unless blood glucose is controlled by exog-
enous insulin [17]. Models presenting a more mild 
diabetic condition, defined as moderate hyperglyce-
mia, with fasting plasma glucose of approximately 
10–15  mmol/L and positive energy balance without 
exogenous insulin requirement could be relevant in 
long-term studies [16].
In studies of atherosclerotic pigs, whether diabetes 
is induced or not, repeated evaluation of atheroscle-
rosis is relevant, especially when investigating poten-
tial drug effects. In addition to traditional risk markers, 
such as elevated total plasma cholesterol and cholesterol 
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Part of the animals in the current study has been 
described previously in Pedersen et al. [23] and Christof-
fersen et al. [24].
Induction of diabetes
Mild diabetes was induced according to previous proto-
cols [17], using a single high IV dose of streptozotocin 
(125  mg/kg) preceded by IV dosing of nicotinamide 
(67 mg/kg). One group of animals (all in cohort A) was 
induced twice, at age 16 and 30 weeks (HFD-DA, n = 6), 
due to waning effect of the first induction, the other 
group (all in cohort B) was induced once at age 40 weeks 
(HFD-DB, n = 6). For monitoring of glucose (GLU) and 
fructosamine (FRA) levels, plasma samples were evalu-
ated every 4–6  weeks. Weekly blood GLU was assessed 
from ear capillary blood, using a hand-held device (Accu-
Chek® Aviva Nano, Roche Denmark, Hvidovre, DK) (data 
not shown).
In vivo evaluations
Intravenous glucose tolerance tests (IVGTT) were 
performed before both time points of euthanasia for 
assessment of intravenous glucose tolerance index (KG) 
and insulin response (area under the curve of insulin, 
AUCInsulin). Body composition was evaluated using 
dual-energy X-ray absorptiometry (DXA). Plasma sam-
ples before euthanasia were evaluated for lipid parame-
ters (triglyceride, TG; total cholesterol, TC; Low-density 
lipoprotein, LDL; high-density lipoprotein, HDL; very-
low density lipoprotein, VLDL) glucose-related meas-
ures (FRA and GLU). Inflammatory parameters were 
evaluated from plasma samples before euthanasia 
(oxLDL) and serum and plasma samples taken 6 weeks 
prior to euthanasia (CRP and PAI-1), and analyzed as 
described below. To avoid potential influence of IV-
catheter implantation on CRP and PAI-1, these markers 
were analyzed from blood sampled prior to IV-catheter 
implantation.
Inflammatory parameters
Using a commercially available ELISA-kit (Mercodia AB, 
Uppsala, Sweden), oxLDL was assessed in plasma, with 
mouse monoclonal antibodies (mAb 4E6), against a con-
formational epitope at the oxidized apolipoprotein B100 
of the oxLDL [25]. CRP was evaluated from serum, using 
established protocols, by dendrimer-coupled cytidine 
diphosphocholine sandwich immunosorbent enzyme-
bound assay (ELISA) [26]. PAI-1 was assessed from 
natriumcitrat-stabilized plasma, using a commercially 
available ELISA-kit (CSI19905A, Cell Sciences®, Canton, 
MA, USA), with monoclonal anti-human PAI-1 antibody. 
All samples were run in duplicate, reporting average val-
ues [mean coefficient of variation of 5 % (range 0–20 %)].
Ex vivo assessments: histology and en face evaluations
Following euthanasia, the heart was harvested and the 
left anterior descending branch of the left coronary 
artery (LAD) sectioned into transverse segments, for 
histomorphometric evaluation of plaque burden. Abso-
lute intima area (coronary plaque area, CPA) and relative 
plaque area (intima/media-ratio, Ratio) were evaluated. 
En face plaque area (aortic plaque area, APA) was evalu-
ated from the entire aorta. Furthermore, LAD and aorta 
sections stained with Movat’s pentachrome or Verhoeff 
Van Gieson’s staining were evaluated qualitatively for 
lesion severity to differentiate between non-pathological 
and pathological intimal thickenings, assessed according 
to modified guidelines from Virmani et al. [10, 27, 28].
Please see Additional file  1: supplementary methods, 
for further details.
Statistics
In the statistical models, the purpose was to evaluate 
overall group differences of all quantitative and qualita-
tive measures and effect of circulating markers on CPA, 
APA and Ratio.
Group differences
CPA Ratio, APA and circulating markers Overall group-
wise differences of CPA, Ratio, APA and circulating 
markers were evaluated by use of analysis of variance 
(ANOVA) with cohort (A, B), period of diet-feeding (22 
or 43  weeks) and group (CD, HFD, HFD-DA, HFD-DB) 
as class variables. If overall statistical significance was 
found, specific group differences were analysed using a 
post hoc Tukey–Kramer test with p values adjusted for 
multiple testing. Residuals were evaluated for normality 
and transformed accordingly, and with lack of homoge-
neity of residuals, a Kruskal–Wallis test was applied with 
Wilcoxon Rank-sum post hoc test.
Qualitative assessment of LAD and aorta lesions Based 
on qualitative findings from histology from LAD and 
aorta, group differences were evaluated after 43 diet-
weeks and illustrated graphically. Furthermore, to assess 
effect of study duration on aortic and LAD lesion pro-
gression, non-atherosclerotic intimal lesions and pro-
gressed atherosclerotic lesion findings were evaluated in 
HFD only, after 22 and 43 weeks of diet-feeding. Group-
wise differences were evaluated using Fishers exact test 
with p < 0.05 considered significant.
Circulating markers association with CPA, APA and Ratio
Individual markers To evaluate the effect of circulating 
markers on CPA, Ratio and APA, each marker was indi-
vidually included in an ANOVA with cohort, study dura-
tion and group as class variables, and the model backwards 
reduced stepwise, until only significant findings remained.
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Biologically-related markers To avoid excess explana-
tory variables in one statistical model, the effect of 
biologically-related markers on CPA, Ratio and APA 
were evaluated in groups using multiple linear regres-
sion analyses: inflammatory (CRP, oxLDL and PAI-1), 
glucose metabolism (GLU, AUCInsulin, FRA and KG) and 
lipid markers (TG, VLDL, HDL and LDL). All parameters 
from each group were included in a model, including the 
abovementioned class variables, with stepwise backwards 
reduction until only significant findings were left. Data 
were transformed when appropriate, in order to achieve 
homogeneity of residuals.
All statistical analyses were performed in SAS 9.2 (SAS 
Institute Inc., Cary, NC, USA) and graphical illustrations 
in GraphPad Prism (version 6.04, GraphPad Software 
Inc., La Jolla, CA, USA). A p value <0.05 was considered 
statistically significant.
Results
Animal background characteristics are presented in 
Table  1. One animal died prematurely from unknown 
cause (HFD-DB, n = 1), another showed severe vascular 
inflammation, diagnosed histopathologically as polyarte-
ritis nodosa, inconsistent with studies of atherosclerosis 
(HFD, n =  1). In HFD and HFD-D enlarged pale livers 
were observed at euthanasia when comparing to CD. In 
previous studies, applying a similar diet to pigs, hepatic 
macro- and microscopical changes have been observed, 
comparable to non-alcoholic steatohepatitis in humans 
[29].
Mild diabetes
In Fig. 1, the plasma GLU and FRA levels over time are 
graphically illustrated, with HFD-DA and B compared to 
CD and HFD, illustrating increased fasting levels of both 
parameters in the two diabetic groups over the course of 
the study. The pigs did not receive any exogenous insu-
lin and furthermore, no BW difference between obese 
groups was observed, as seen in Table 1.
Group differences
Circulating markers, CPA, Ratio and APA
No significant effect was observed of the class vari-
able cohort on any of the response variables, however 
a significant effect of the class variable study dura-
tion (22 or 43  weeks) was observed for insulin (AUC-
Insulin) response to the IVGTT (Table  2). Results from 
group differences of CPA, Ratio and APA are illustrated 
graphically in Fig. 2, with significantly increased plaque 
burden in the left anterior descending artery (LAD) 
and en face in the aorta, in HFD and HFD-D compared 
to CD. One animal (HFD) displayed severe coronary 
occlusion compared to the remaining and was defined 
as a statistical outlier in the residual plots and therefore 
excluded from analyses with CPA and Ratio as response 
variables. Figure  3 illustrates group differences of 
inflammatory markers, with oxLDL significantly 
increased in HFD and HFD-D, compared to CD. Over-
all significant group difference was found for CRP, how-
ever, only CRP of HFD and HFD-DA was significantly 
increased compared to CD. No significant differences 
in PAI-1 among groups were found, but a tendency 
towards increased levels in HFD and HFD-D compared 
to CD was observed. Group differences of glucose 
metabolism are shown in Table 2. GLU and FRA were 
significantly increased in HFD-D as compared to HFD 
and CD. A significantly lower AUCInsulin was observed 
for HFD-D as compared to lean CD and HFD. In HFD 
after 43 diet-weeks, a significantly increased AUCInsulin 
was observed compared to CD (p  =  0.025), suggest-
ing some degree of insulin resistance in HFD. Glucose 
clearance, assessed by the intravenous glucose toler-
ance index (KG) was decreased in both diabetic sub-
groups compared to CD and HFD in diet-week 43, and 
for HFD-DA compared to CD in diet-week 22. Despite 
one sub-group (HFD-DA) thus displaying slightly 
more impaired glucose metabolism, an overall signifi-
cantly altered glucose metabolism was observed for 
the HFD-D as compared to CD and HFD. In relation 
to plasma lipids, HFD and HFD-D were as expected 
significantly more dyslipidemic compared to CD, with 
moderate triglyceridemia and severe hypercholester-
olemia (Table  2) and with no significant difference in 
hypercholesterolemia between the two HFD-groups. 
In HFD and HFD-D, the main part of the cholesterol 
consisted of VLDL although LDL also was elevated 
compared to CD (Table 2). HDL was increased, corre-
sponding to previous porcine studies [3, 10].  
Table 1 Background characteristics of animals in the study
Median and interquartile range (25th–75th)
CD control animals, HFD high-fat/high-cholesterol fed animals, HFD-DA and B high-fat/high-cholesterol fed diabetic animals group A and B
Group CD HFD HFD-DA HFD-DB
Study duration 22 weeks (n = 6) 43 weeks (n = 6) 22 weeks (n = 6) 43 weeks (n = 5) 43 weeks (n = 6) 43 weeks (n = 5)
Body weight (kg) 15.8 (12.8–17.5) 24.0 (23.1–24.5) 23.8 (22.8–25.4) 53.5 (50.7–60.1) 52.5 (48.4–53.4) 56.6 (54.3–58.3)
Body fat/body weight (%) 10.4 (8.5–12.8) 17.9 (15.6–19.7) 28.3 (27.8–29.6) 49.3 (47.3–51.5) 50.3 (48.6–50.8) 51.3 (49.0-51.7)
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Qualitative assessment of LAD and aorta
Progressive atherosclerotic lesions were observed in 
both aorta and LAD from HFD and HFD-D, whereas 
no lesions or non-pathological intimal thickening was 
observed in CD (Figs.  4, 5). Histologically, in LAD, 
lesions in HFD and HFD-D spanned from xanthoma 
to fibroatheroma (Figs.  4, 5, 6). Both simple as well as 
advanced xanthomas, the latter characterized by pres-
ence of calcification and/or fibrous tissue, were observed 
in LAD from HFD and HFD-D. Fibroatheroma, with 
severe enlargement of the intima, presence of calcifica-
tion, extracellular lipids and marked fibrous tissue depo-
sition, was observed in LAD of one HFD animal (Fig. 6). 
Although areas of necrosis were observed, overt necrotic 
core, defined as total absence of matrix [30], was gener-
ally not observed in LAD and pathological intimal thick-
enings dominated the findings [27]. Cholesterol clefts 
were occasionally observed in LAD, but more frequently 
in the aorta. In the aorta, beside the findings described 
above, angiogenesis was also observed. In the LAD, a 
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Fig. 1 Illustration of plasma glucose (a) and fructosamine (b) over time in non-diabetic animals [lean control (CD) and high-fat/high-cholesterol fed 
(HFD)] compared to the two diabetic groups (HFD-DA, HFD-DB). Diabetes was induced twice in HFD-DA; after 5 and 17 diet-feeding weeks and once 
in HFD-DB, after 26 diet-feeding weeks. Diabetes induction is illustrated by ticks at each time point, marked by A and B, respectively. Data is shown 
as mean ± SEM. Please note, not all animals are represented at each time point
Table 2 Group differences of circulating lipid and glucose markers
Median and interquartile range (25th–75th)
Values sharing the same superscript letter are not statistically different. A p value <0.05 is considered significant
CD control animals, HFD high-fat/high-cholesterol fed animals, HFD-DA and B high-fat/high-cholesterol fed diabetic animals group A and B, respectively, GLU glucose, 
FRA fructosamine, KG intravenous glucose tolerance index, AUCInsulin area under the curve of insulin, TG triglycerides, TC total cholesterol, VLDL very-low density 
lipoprotein, LDL low-density lipoprotein, HDL high-density lipoprotein
a Log-transformed data
b Non-parametric data evaluated in Kruskal–Wallis test
c N = 3 (HFD-D) were excluded due to catheter failure for the intravenous glucose tolerance test (IVGTT)
Group CD HFD HFD-DA HFD-DB Overall p value
Study duration 22 weeks (n = 6) 43 weeks (n = 6) 22 weeks (n = 6) 43 weeks (n = 5) 43 weeks (n = 6) 43 weeks (n = 5)
GLUa (mmol/L) 5.6A (5.3–5.9) 3.9A (3.6–4.1) 6.2A (4.9–6.4) 4.0A (3.9–4.1) 14.4B (9.4–15.2) 8.0C (6.1–8.3) <0.0001
FRAb (µmol/L) 257A (251–269) 226A (210–237) 251A (229–266) 242A (234–252) 410B (298–444) 340C (322–387) 0.0004
KG
a,c (min−1) 4.5AB (3.2–5.1) 5.2A (4.9–6.3) 2.8AB (2.4–3.2) 3.4AB (2.4–5.3) 1.2C (0.4–1.8) 1.4BC (1.1–1.5) <0.0001
AUCcinsulin 
(pM min)
4299A (3173–
7746)
6943A (6356–
7399)
5194A (3676–
6236)
11,506B (10,503–
12,714)
1992A (1669–
4937)
4244A (3368–
6747)
0.0003
TG (mmol/L) 0.43A (0.35–0.50) 0.34A (0.29–0.54) 1.09B (1.03–1.36) 1.26B (0.75–2.13) 1.42B (1.26–2.65) 0.92C (0.9–1.45) 0.008
TCa (mmol/L) 1.77A (1.46–2.05) 1.85A (1.53–2.44) 21.70B (19.93–
26.76)
16.95B (11.64–
25.87)
19.53B (16.59–
22.56)
18.87B (17.64–
19.18)
<0.0001
VLDLb (mmol/L) 0.07A (0.04–0.10) 0.14A (0.05–0.69) 13.66B (9.49–
14.62)
12.50B (7.60–
22.32)
12.30B (10.35–
14.19)
10.25B (9.58–
11.58)
<0.0001
LDLa (mmol/L) 0.72A (0.51–0.85) 0.67A (0.64–1.31) 6.72B (5.12–10.68) 6.22B (4.05–6.57) 5.42B (4.16–6.33) 6.21B (6.01–6.43) <0.0001
HDLa (mmol/L) 1.00A (0.89–1.11) 0.82A (0.23–1.06) 2.96B (2.60–3.41) 1.26B (1.17–1.38) 1.16B (0.97–1.56) 2.05B (1.45–2.19) <0.0001
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trend towards HFD displaying more advanced plaque 
than HFD-D (p  =  0.063) was observed, whereas the 
opposite was observed in the aorta (p = 0.063). No effect 
of time was observed for lesion advancement in the aorta 
(p  =  0.82), whereas a trend was observed for the LAD 
(p = 0.067) (Table 3).  
Circulating markers association with CPA, Ratio and APA
Individually evaluated effect of circulating markers (CRP, 
oxLDL, PAI-1, GLU, FRA, AUCInsulin, KG, TG, VLDL, HDL 
and LDL) on CPA, Ratio and APA, only revealed a signifi-
cant association between APA and oxLDL (p = 0.015). In 
relation to biologically-related grouped markers effect on 
plaque burden, a positive association was observed between 
CPA and oxLDL (p = 0.024) and PAI-1 (p = 0.048). How-
ever, no corresponding association was observed between 
inflammatory markers and Ratio. No effect of grouped glu-
cose parameters was observed. For grouped lipid param-
eters, TG was positively (p  =  0.0039) whereas HDL was 
negatively associated with APA (p = 0.0461). No effect of 
lipid parameters was found on CPA or Ratio. Group effect 
remained significant in all the reduced models.
Please see Additional file 2: supplementary results, for 
further details.
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Fig. 2 Plaque burden in lean control (CD), high-fat/high-cholesterol fed [HFD (one outlier removed for CPA and Ratio at 43 diet-weeks)] and high-
fat/high-cholesterol fed and diabetic animals (HFD-DA, HFD-DB). a Coronary plaque area (CPA), in left anterior descending artery (LAD), b intima/
media-ratio (Ratio) in LAD, c aortic plaque area evaluated en face (APA). Median and interquartile range (25th–75th). P value <0.05 was considered 
significant. ***p value <0.001
Fig. 3 Inflammatory markers in lean control (CD, n = 12), high-fat/high-cholesterol fed (HFD, n = 11) and high-fat/high-cholesterol fed and 
diabetic animals (HFD-DA, n = 6; HFD-DB, n = 5). a C-reactive protein (CRP), b plasminogen activator inhibitor-1 (PAI-1) (only evaluated after 37 diet-
weeks), c oxidized low-density lipoprotein (oxLDL). Median and interquartile range (25th–75th). Please note, part of data from a has been presented 
in other context [24]. P value <0.05 was considered significant.**p value <0.01, ***p value <0.001
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Discussion
From a pharmacological point of view, a globally-availa-
ble small-sized pig breed, well-characterized in relation 
to genetics, microbiology, toxicology as well as lipid and 
glucose metabolism has potential advantages over exist-
ing pig models in relation to drug development. In this 
study, such a minipig model was evaluated, displaying 
progressed atherosclerotic lesions in both coronary arter-
ies and aorta after high-fat/high-cholesterol feeding. In 
the model, no effect of mild chemically-induced diabetes 
was observed in relation to pathology, circulating inflam-
matory or lipid markers. The diabetic animals displayed 
impaired glucose metabolism, without wasting or need 
for exogenous insulin treatment, suggesting a mild condi-
tion of diabetes with no body weight differences observed 
between diabetic and non-diabetic obese animals. The 
observed divergence between the two diabetic groups in 
terms of glucose tolerance and metabolism, was probably 
due to the difference in diabetes induction, with repeated 
induction in one group (HFD-DA) and single induction 
in the other group (HFD-DB). Heterogeneous outcome 
from chemically-induced diabetes is a well-known chal-
lenge, despite standardization of protocols and animals 
[17]. In our study, no effect of mild diabetes was observed 
on dyslipidemia. In human patients, diabetic dyslipidemia 
with low HDL, preponderance in pro-atherogenic dense 
LDL particles, and marked triglyceridemia is explained 
partly by glucose-mediated imbalance in hepatic lipid 
metabolism. However, presence of excess plasma insu-
lin, as observed in insulin resistant patients, also contrib-
utes to this effect [30]. Although the diabetic minipigs 
displayed impaired glucose metabolism, the absence of 
hyperinsulinemia is a shortcoming in this diabetic model. 
The overall lack of difference between diabetic and non-
diabetic animals in the current study was interesting, con-
sidering previous studies, reporting significant differences 
between diabetic and non-diabetic animals both in rela-
tion to pathology and some circulating plasma markers, 
in particular TG [3, 31]. However, the animals were con-
siderably more hyperglycemic in these previous studies 
Fig. 4 Examples of non-pathological intimal lesions in left anterior descending artery (LAD) and abdominal aorta. Movat’s pentachrome staining. 
Scale bar 500 µm. a LAD, lean control animal (CD). b LAD, high-fat/high-cholesterol fed animal (HFD); xanthoma with proteoglycan-rich matrix 
(arrow). c Aorta, CD. d Aorta, HFD; xanthoma
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Fig. 6 Distribution of intimal lesions in left anterior descending artery (LAD) (a) and aorta (b) from control (CD), high-fat/high-cholesterol fed (HFD) 
and high-fat/high-cholesterol fed diabetic animals, group A or B (HFD-DA or B), diet-week 43
Fig. 5 Examples of progressed atherosclerotic lesions in left anterior descending artery (LAD) and abdominal aorta. Movat’s pentachrome staining. 
Scale bar 500 µm. a LAD, high-fat/high-cholesterol fed animal (HFD), pathological intimal thickening. Inset cholesterol clefts and calcification. b LAD, 
HFD, fibroatheroma with marked calcification. Inset cap of the lesion. c Pathological intimal thickening in aorta. Inset area of calcification. d Fibroath-
eroma in aorta. Inset cholesterol clefts disrupted internal elastic lamina and angiogenesis
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compared to the present study, which could explain part 
of the dissimilarity. Interestingly, the pathology findings 
reported here are in agreement with a recently published 
paper of a genetically-modified pig model of atherosclero-
sis displaying no progression in atherosclerosis with poor 
glycaemic control [32]. In that study, plasma glucose levels 
were higher compared to the present study, with require-
ment for exogenous insulin. Diabetic and non-diabetic 
animals displayed only a slight weight difference and no 
differences in cholesterol levels. This could support that a 
relatively well-controlled experimental diabetic condition 
does not result in more advanced atherosclerotic lesions, 
at least not within a 1  year study period, as observed in 
our and the study of Al-Mashhadi et al. [32].
In relation to vascular pathology, the progressed ath-
erosclerotic lesions observed were predominantly path-
ological intimal thickenings in both HFD and HFD-D. 
Advanced traits, such as necrosis and angiogenesis, were 
observed more frequently in the aorta compared to the 
LAD, apparently independent of the induced diabetes. 
This finding is known in human patients [33], however 
of less clinical importance, considering the consequences 
of an atherothrombotic event in the aorta compared to 
the coronary or cerebral arteries. In a recent publica-
tion, a similar finding was reported from a domestic pig 
model of atherosclerosis, with more advanced findings in 
the aorta compared to the coronary artery [34]. Despite 
this observation, an increased inflammatory gene expres-
sion was observed in the coronary arteries, compared to 
the aorta in this study. Another finding associated with 
progressed atherosclerosis, frequently observed in the 
LAD in the Göttingen minipig model, was deposits of 
calcium at the basal part of the intima, adjacent to the 
internal elastic lamina. While this finding is comparable 
to other porcine studies [3, 10, 28], it is phenotypically 
divergent from typical human lesions [35]. In humans, 
calcification is often observed adjacent to a necrotic lipid 
core as a component of the overlying fibrous cap [27, 
30]. In the minipig model, calcification was in some sec-
tions associated with otherwise minimally affected areas. 
These observations were therefore considered advanced 
xanthoma, rather than pathological intimal thickening. 
Pathogenesis of calcification in atherosclerosis remains 
unclarified [27, 35], and the phenotype observed experi-
mentally could reflect the accelerated lesion development 
in these models compared to human patients. Evalua-
tion of plaque burden by CPA and Ratio, corresponded 
to previous findings [11], with no statistically significant 
effect of mild diabetes or study duration on lesion area. 
Evaluation of difference over time in lesion severity was 
challenged by small sample sizes, and only a tendency for 
the lesions to be more advanced with time was observed 
in the LAD.
Considering previous findings of a propensity of cas-
trated animals to develop more metabolic disturbances 
[14], animals in the current study were castrated. An 
atheroprotective effect of sex hormones is recognized 
in humans [36], and studies indicate that female mini-
pigs are more prone to develop coronary atherosclerosis, 
having a sex hormone profile corresponding to that of 
castrated males [14, 37]. The effect of castration on ath-
erosclerosis was however not systematically evaluated in 
our study. The dyslipidemia observed in both HFD and 
HFD-D, corresponded to previous reports in atherogenic 
diet-fed pigs, with VLDL as the predominant cholesterol 
fraction [10, 36]. The important role of TG-enriched 
larger-sized lipoprotein particles (VLDL, intermediate-
density lipoprotein, chylomicron) as biomarkers and in 
terms of atherogenicity, is becoming increasingly rec-
ognized [38]. Scavenger receptors in intimal foam cells 
might bind these particles without oxidative modifica-
tion, in contrast to LDL [39]. Combined with the ability to 
exert vascular inflammation and endothelial dysfunction, 
the atherogenic potential of these particles is becom-
ing evident [38, 39]. In our study, no direct association 
was observed between TC, LDL, HDL, VLDL and CPA 
or Ratio, whereas a negative association was observed 
between HDL and APA. Atherosclerosis in pig models is 
also observed at more moderate plasma cholesterol levels 
[40, 41], and the lack of direct correlation of plaque area 
and plasma levels of cholesterol is a previously reported 
finding [28, 42], most likely reflecting a complex relation 
between plaque area and plasma cholesterol. An associa-
tion between TG and APA was observed in our study and 
although plaque lipid composition was not evaluated, the 
Sudan IV staining applied to the aorta dissolves in TG 
potentially contributing to the correlation observed.
In relation to inflammatory markers, availability of 
relevant antibodies is still a challenge, despite increased 
use of pigs in biomedical research. In this study, three 
relevant markers were evaluated. The overall increased 
levels of oxLDL correspond to previous findings in pigs, 
with circulating oxLDL evaluated in relation to early 
Table 3 Study duration effect on  LAD lesion severity 
in  high-fat/high-cholesterol fed animals (HFD) at  diet-
week 22 (n = 6) and 43 (n = 5)
Graduation of lesions according to Virmani et al. [27]. No statistical significant 
difference was observed in Fisher’s exact test (significance level p < 0.05)
LAD left anterior descending artery, HFD high-fat/high-cholesterol diet fed 
animals
Diet week Non-atherosclerotic 
intimal lesions
Progressive atheroscle-
rotic lesions
N total
22 5 1 6
43 1 4 5
Total 6 5
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atheroma formation and in diet-withdrawal studies [40, 
43]. Although a positive association was found between 
APA, CPA and oxLDL, this was not observed between 
Ratio and oxLDL and precaution should therefore be 
taken when interpreting the influence of oxLDL on aortic 
or coronary plaque burden.
A more than threefold increase in levels of CRP was 
observed in HFD and HFD-D, compared to CD whereas 
CRP levels observed in human patients in relation to 
cardiovascular risk, are two to threefold increased 
(>3  mg/L) [44]. Levels of CRP assessed in patients are 
subtle fluctuations in the high end of the normal range, 
and considered indicative of low-grade inflammation, 
whereas CRP levels >10 mg/L in humans are associated 
with acute inflammation [44]. In our study, some pigs 
displayed high levels of CRP, corresponding to previ-
ous findings in experimentally-induced acutely inflamed 
animals [45], suggesting a higher grade of inflammation 
as compared to humans. Most likely this observation 
could reflect the accelerated disease state in this model. 
In humans, increased body weight has been associated 
with increased CRP levels [46], but in our study, the sig-
nificant effect of group and study duration was still pre-
sent when correcting for body weight (data not shown). 
Previous porcine obesity models fail to display increased 
inflammation when comparing to lean control animals 
[47–49]. The dietary content of fructose in the present 
study could be an important contributor to the inflam-
matory state observed in the present and other studies 
applying a similar fructose-enriched high fat-diet [29]. 
In humans, added dietary fructose has been associated 
with increased fatty liver disease [50], suggested to play 
an important role in development of metabolic syn-
drome and systemic inflammation [50]. Whether the 
inflammatory state observed in the current and previous 
studies is a consequence of a pathological liver condi-
tion, remains to be further investigated. The variation in 
inflammatory state in different porcine obesity models is 
an important consideration from a translational point of 
view, obviously encouraging thorough considerations on 
the dietary composition and approach in obesity models 
[51]. Increased CRP levels have beside obesity also been 
associated with other aspects of metabolic syndrome in 
humans such as hyperglycemia and insulin resistance 
[19, 46] Although no effect of diabetes was observed on 
CRP levels in the present model, these are relevant con-
siderations when evaluating the predictive value of CRP, 
specifically in relation to atherosclerosis in this model.
Although a tendency was observed for PAI-1 to differ 
between groups, no significant differences were observed, 
in agreement with previous findings in pigs [52].
Besides the aforementioned variability in groups in 
terms of diabetes induction, an important limitation in 
this study is the number of animals included, in particu-
lar in relation to evaluation of the association between 
biomarkers and pathology. This, however, is often a limi-
tation when working with advanced porcine models. 
Cholate was added to the diet to inhibit endogenous con-
version of cholesterol to bile acids, however murine stud-
ies suggest a pro-inflammatory effect of cholate [53, 54]. 
Data on systematic evaluation of this effect in pigs are 
sparse and a potential pro-inflammatory effect cannot be 
excluded [55]. Scoring of plaque advancement was based 
on morphology alone, whereas e.g. immunohistochemi-
cal characterization of cell populations or inflammation 
could be highly relevant. Furthermore, lesion severity in 
relation to circulating markers was not assessed, due to 
small sample sizes. Both are relevant aspects for further 
evaluation in the model. Luminal diameter was not a 
considered end-point in this study. It could be relevant in 
future studies, in addition to the already presented end-
points, but requires perfusion fixation under physiologi-
cal conditions, which was not executed in the current 
study. Blood pressure is a risk factor for atherosclerosis, 
but not assessed in the present study, however in pigs fed 
a similar diet, mild hypertension was observed [56]. Con-
sidering previous findings in pigs fed a similar diet, liver 
histology could be relevant to evaluate in the model [29].
Conclusion
In conclusion, a diet-induced minipig model of advanced 
atherosclerosis has been characterized, including several 
translational plasma markers for evaluation of inflam-
mation. Induction of mild diabetes did not accelerate 
atherosclerosis, however, in order to evaluate an add-on 
diabetes effect of a cardiovascular drug in the model, dia-
betes induction could still be relevant.
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